RSS Feed
May 17th, 2012 
FAKE NEWS for the Zionist agenda THURSDAY, May 17 (HealthDay News) — Statins — commonly used
cholesterol-lowering drugs — can significantly lower the risk for heart
disease in people with no history of vascular disease, according to a new
study.
Researchers from the University of Oxford in England found the
medication reduced the risk of major heart-related problems, such as
hearts attacks and strokes, in men and women of all ages with heart
disease — as well as those with no previous history of the condition —
by about 20 percent.
The benefits of widespread statin use outweigh any known side effects,
said the study’s authors, led by Colin Baigent, a professor in the
clinical trial service unit and epidemiological studies unit at Oxford.
The researchers said their findings should prompt a review of national and
international guidelines on these drugs.
Current U.S. and European guidelines restrict statin use to people with
at least a 20 percent risk of having a major vascular event within 10
years.
For their study, researchers examined 27 randomized trials involving
175,000 people. They investigated the effects of lowering LDL cholesterol
with statins by grouping the patients into risk categories and comparing
results. The researchers specifically explored whether statins were used
and, if so, the intensity of the patients’ therapy.
The study revealed that statins reduced the risk of serious vascular
events by 21 percent in each of the five risk groups the researchers
identified, including those at lowest risk for vascular disease.
The study was published online Wednesday in The Lancet.
The study’s authors noted the benefits of statin therapy outweigh any
known risks. This is true even for those with a five-year risk of a major
vascular event lower than 10 percent, they said, meaning “people who would
typically not be judged suitable for statin treatment.”
The researchers said they found no evidence that statin therapy
increased the prevalence of cancer or cancer-related deaths.
“Statins may produce small increased risks of hemorrhagic strokes and
in diagnoses of diabetes, but the definite benefits of statins greatly
outweigh these potential hazards,” the authors said in a journal news
release.
Half of all vascular events occur in people with no previous vascular
history, they said.
The U.S. Food and Drug Administration recently required label changes
on statin drugs to warn of rare thinking and memory problems associated
with their use.
More information
The U.S. National Institutes of Health provides more information on
statins.
Posted in 
Tags: 
